Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Involvement of NMDA receptors in the antidepressant-like effect of tramadol in the mouse forced swimming test.

Ostadhadi S, Norouzi-Javidan A, Chamanara M, Akbarian R, Imran-Khan M, Ghasemi M, Dehpour AR.

Brain Res Bull. 2017 Sep;134:136-141. doi: 10.1016/j.brainresbull.2017.07.016. Epub 2017 Jul 25.

PMID:
28754288
2.

Ketamine upregulates eNOS expression in human astroglial A172 cells: Possible role in its antidepressive properties.

Yuhas Y, Ashkenazi S, Berent E, Weizman A.

J Neuroimmunol. 2017 Apr 15;305:75-81. doi: 10.1016/j.jneuroim.2016.12.017. Epub 2017 Jan 26.

PMID:
28284350
3.

Rapid and sustained antidepressant properties of an NMDA antagonist/monoamine reuptake inhibitor identified via transporter-based virtual screening.

Talbot JN, Geffert LM, Jorvig JE, Goldstein RI, Nielsen CL, Wolters NE, Amos ME, Munro CA, Dallman E, Mereu M, Tanda G, Katz JL, Indarte M, Madura JD, Choi H, Leak RK, Surratt CK.

Pharmacol Biochem Behav. 2016 Nov - Dec;150-151:22-30. doi: 10.1016/j.pbb.2016.08.007. Epub 2016 Aug 26.

PMID:
27569602
4.

Pharmacological evidence for the involvement of the NMDA receptor and nitric oxide pathway in the antidepressant-like effect of lamotrigine in the mouse forced swimming test.

Ostadhadi S, Ahangari M, Nikoui V, Norouzi-Javidan A, Zolfaghari S, Jazaeri F, Chamanara M, Akbarian R, Dehpour AR.

Biomed Pharmacother. 2016 Aug;82:713-21. doi: 10.1016/j.biopha.2016.05.035. Epub 2016 Jun 14.

PMID:
27470415
5.

Role of calcium, glutamate and NMDA in major depression and therapeutic application.

Deutschenbaur L, Beck J, Kiyhankhadiv A, Mühlhauser M, Borgwardt S, Walter M, Hasler G, Sollberger D, Lang UE.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:325-33. doi: 10.1016/j.pnpbp.2015.02.015. Epub 2015 Mar 4. Review.

PMID:
25747801
6.

Effects of ketamine and N-methyl-D-aspartate on fluoxetine-induced antidepressant-related behavior using the forced swimming test.

Owolabi RA, Akanmu MA, Adeyemi OI.

Neurosci Lett. 2014 Apr 30;566:172-6. doi: 10.1016/j.neulet.2014.01.015. Epub 2014 Feb 12.

PMID:
24530380
7.

Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule.

Hillhouse TM, Porter JH.

Behav Pharmacol. 2014 Feb;25(1):80-91. doi: 10.1097/FBP.0000000000000014.

PMID:
24370559
8.

Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder.

Duncan WC Jr, Selter J, Brutsche N, Sarasso S, Zarate CA Jr.

J Affect Disord. 2013 Feb 15;145(1):115-9. doi: 10.1016/j.jad.2012.05.042. Epub 2012 Aug 5.

9.

The promise of rapidly acting antidepressants: challenges and opportunities.

Smith MA, Pathak S.

Biol Psychiatry. 2012 Aug 15;72(4):252-3. doi: 10.1016/j.biopsych.2012.05.033. No abstract available.

PMID:
22840946
10.

Impact of early-life stress, on group III mGlu receptor levels in the rat hippocampus: effects of ketamine, electroconvulsive shock therapy and fluoxetine treatment.

O' Connor RM, Pusceddu MM, Dinan TG, Cryan JF.

Neuropharmacology. 2013 Mar;66:236-41. doi: 10.1016/j.neuropharm.2012.05.006. Epub 2012 May 17.

PMID:
22609536
11.

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.

Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, Kammerer WA, Quezado Z, Luckenbaugh DA, Salvadore G, Machado-Vieira R, Manji HK, Zarate CA Jr.

Arch Gen Psychiatry. 2010 Aug;67(8):793-802. doi: 10.1001/archgenpsychiatry.2010.90.

12.

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.

DiazGranados N, Ibrahim LA, Brutsche NE, Ameli R, Henter ID, Luckenbaugh DA, Machado-Vieira R, Zarate CA Jr.

J Clin Psychiatry. 2010 Dec;71(12):1605-11. doi: 10.4088/JCP.09m05327blu. Epub 2010 Jul 13.

13.

NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test.

Ghasemi M, Raza M, Dehpour AR.

J Psychopharmacol. 2010 Apr;24(4):585-94. doi: 10.1177/0269881109104845. Epub 2009 Apr 7.

PMID:
19351802
14.

Toxicology profile of N-methyl-D-aspartate antagonists delivered by intrathecal infusion in the canine model.

Yaksh TL, Tozier N, Horais KA, Malkmus S, Rathbun M, Lafranco L, Eisenach J.

Anesthesiology. 2008 May;108(5):938-49. doi: 10.1097/ALN.0b013e31816c902a.

PMID:
18431131
15.

Effect of gabaergic, glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced seizures and status epilepticus.

Freitas RM, Sousa FC, Viana GS, Fonteles MM.

Neurosci Lett. 2006 Nov 13;408(2):79-83. Epub 2006 Sep 29.

PMID:
17011125
16.

Treatment options in postherpetic neuralgia.

Bonezzi C, Demartini L.

Acta Neurol Scand Suppl. 1999;173:25-35; discussion 48-52. Review.

PMID:
10819089
17.

Current status of NMDA antagonist interventions in the treatment of nonketotic hyperglycinemia.

Deutsch SI, Rosse RB, Mastropaolo J.

Clin Neuropharmacol. 1998 Mar-Apr;21(2):71-9. Review.

PMID:
9579291
18.

Desmethylimipramine potentiates NMDA responses in a mouse cortical slice preparation.

Lancaster JM, Davies JA.

Neuroreport. 1991 Nov;2(11):665-8.

PMID:
1725726
19.

Supplemental Content

Loading ...
Support Center